When does COEPTIS THERAPEUTICS HOLDING (COEP) report earnings?
COEPTIS THERAPEUTICS HOLDING (COEP) will report earnings on 2026-05-14.
NASDAQ:COEP • US19207A2078
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COEPTIS THERAPEUTICS HOLDING (COEP).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-09-22 | Ladenburg Thalmann | Initiate | Buy |
| 2023-05-18 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-10 | EF Hutton | Reiterate | Buy |
| 2023-04-19 | JonesTrading | Initiate | Buy |
| 2023-04-05 | EF Hutton | Reiterate | Buy |
| 2023-03-29 | EF Hutton | Reiterate | Buy |
| 2022-12-13 | EF Hutton | Initiate | Buy |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 75K | -100.00% | 1.785M | 50.174M | 4.386M -91.26% | 20.808M 374.42% | 58.242M 179.90% | ||||||
| EBITDA YoY % growth | N/A | N/A | -13.599M | -144.10% | 5.202M 38.27% | 6.018M 129.37% | 7.038M 16.95% | -20.094M -385.51% | -20.4M -1.52% | 100.00% | 4.08M | 17.442M 327.50% | |
| EBIT YoY % growth | -100 | -566.7K -566,600.00% | -14.046M -2,378.54% | -2.346M -143.46% | -18.39M 37.15% | -12.435M 42.14% | -15.691M -26.18% | -17.584M -12.07% | -19.716M -12.12% | -71.298M -261.63% | -63.24M 11.30% | -35.19M 44.35% | |
| Operating Margin | N/A | N/A | -18,727.87% | N/A | -1,030.26% | N/A | N/A | N/A | -39.29% | -1,625.58% | -303.92% | -60.42% | |
| EPS YoY % growth | N/A | N/A | N/A | 3.47 | -17.34 -600.00% | -0.27 98.47% | -0.17 34.62% | -0.17 | -0.18 -5.88% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.04 98.15% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -3.24M 3.76% |
All data in USD
COEPTIS THERAPEUTICS HOLDING (COEP) will report earnings on 2026-05-14.
The consensus EPS estimate for the next earnings of COEPTIS THERAPEUTICS HOLDING (COEP) is -0.04 USD and the consensus revenue estimate is 0 USD.
The number of analysts covering COEPTIS THERAPEUTICS HOLDING (COEP) is 6.